Study suggests that preserved dopamine in certain brain regions may actually contribute to tremor symptoms, challenging common beliefs.

FDA IND approval for TB006 is a major achievement for TrueBinding and a significant potential advancement for the treatment of Parkinson’s Disease worldwide,” said Alan K. Jacobs, M.D., FAAN, Chief ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.

finding that preserved dopamine in certain brain regions may actually contribute to tremor symptoms, challenging common beliefs. Parkinson's disease (PD) is a progressive neurological disorder known ...

Rest tremor in Parkinson’s disease is linked to dopamine activity in the caudate nucleus, challenging conventional beliefs about dopamine loss and motor symptoms.

Parkinson's Disease (PD) is a progressive neurological disorder that affects millions of people worldwide, characterized by tremors, stiffness, ...

A team of neurologists, bioengineers and radiologists has found that two neurons in the human brain that code for dopamine ...

Findings suggest semaglutide and other GLP-1 agonists may significantly reduce alcohol use disorder hospitalizations, ...

Researchers from the Champalimaud Foundation have shed light on the puzzling relationship between dopamine and rest tremor in ...

Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson’s ...

Enhanced Cognitive Performance: Vyvamind is designed to serve as a potent neurostimulant, utilizing a precise blend of ...